Mito Assist โ FORZINITY Patient Support
Mighty Therapeutics with AnovoRx
The patient support program for FORZINITY (elamipretide): insurance benefits investigation and submission support, copay assistance for commercially insured patients, a patient assistance program providing free drug to uninsured or underinsured patients, at-home subcutaneous injection training, and dedicated case management. AnovoRx is the exclusive US specialty pharmacy. Copay caps and income criteria are confirmed at enrollment and are not published.
FORZINITY is the approved Barth syndrome treatment, so this program exists specifically for BTHS patients starting or continuing on it.
US patients prescribed FORZINITY (approved for patients weighing at least 30 kg); program tier depends on insurance status.
Call 1-833-458-9099 or start with the Patient Enrollment Form on the AnovoRx site, typically initiated with the prescriber.
/grants/mito-assist-forzinity-patient-support/
Last updated August 28, 2026 ยท Suggest an update to this entry